
    
      This is a randomized double-blind placebo-controlled study in pre-frail elderly. Measurement
      of frailty status based on Fried frailty phenotype criteria (weight loss, weakness,
      exhaustion, slowness, low physical activity level) .

      Subjects who fulfill eligibility criteria will be randomized into 2 groups, one group will
      received cholecalciferol 4000 IU once daily and the other group will received placebo once
      daily. Each subjects in both groups will received calcium lactate 500 mg once daily.
      Intervention will be held for 12 weeks.

      Handgrip strength and gait speed will be assessed at baseline, every 4 weeks, and at week 12.
      Other outcome measures will be assessed at baseline and at week 12.
    
  